These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3080707)

  • 1. Acute effects of physostigmine and neostigmine in man.
    Janowsky DS; Risch SC; Kennedy B; Ziegler MG; Huey LY
    Mil Med; 1986 Jan; 151(1):48-51. PubMed ID: 3080707
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic-adrenergic balance: Part 1. Relationship between central and peripheral sensitivities.
    Fritze J; Sofic E; Müller T; Pfüller H; Lanczik M; Riederer P
    Psychiatry Res; 1990 Dec; 34(3):259-70. PubMed ID: 1963691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of physostigmine, tetraethylpyrophosphate, and neostigmine on the blood pressure and pressor reflexes of the carotid sinus in rats].
    HORNYKIEWICZ O; KOBINGER W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(5):493-500. PubMed ID: 13348675
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertensive effect of esterase inhibitors, E 605, eserine and prostigmine].
    VON EICKSTEDT KW; ERDMANN WD; SCHAEFER KP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 226(5):435-41. PubMed ID: 13309379
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of eserine and neostigmine on the blood pressure of conscious rats.
    MEDAKOVIC M; VARAGIC V
    Br J Pharmacol Chemother; 1957 Mar; 12(1):24-7. PubMed ID: 13413146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cardiovascular effects of physostigmine in humans.
    Janowsky DS; Risch SC; Huey LY
    Hypertension; 1985; 7(1):140-5. PubMed ID: 3980055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of physostigmine (1.0 mg s.c.) and scopolamine (0.6 mg s.c., applied 15 and 30 minutes after physostigmine) on the blood pressure, the body temperature, and the heart rate in man.
    Hrbek J; Macáková J; Komenda S; Siroká A; Hrbek J
    Acta Univ Palacki Olomuc Fac Med; 1986; 115():73-89. PubMed ID: 2951977
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of antihypertensive agent-induced postural hypotension with physostigmine.
    Park KH; Long JP; Cannon JG
    Arch Int Pharmacodyn Ther; 1991; 311():155-65. PubMed ID: 1665057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of physostigmine infusion on patients with panic disorder.
    Rapaport MH; Risch SC; Gillin JC; Golshan S; Janowsky D
    Biol Psychiatry; 1991 Apr; 29(7):658-64. PubMed ID: 2054436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic and dopaminergic mechanisms in Huntington's chorea.
    Aquilonius SM; Sjöström R
    Life Sci I; 1971 Apr; 10(7):405-14. PubMed ID: 4325138
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of physostigmine doses (0.1 mg, 0.3 mg, 0.6 mg) on the blood pressure, the body temperature and the heart rate in man.
    Hrbek J; Macáková J; Komenda S; Siroká A; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1985; 112():263-77. PubMed ID: 2938437
    [No Abstract]   [Full Text] [Related]  

  • 12. Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release.
    Janowsky DS; Risch SC; Kennedy B; Ziegler M; Huey L
    Psychopharmacology (Berl); 1986; 89(2):150-4. PubMed ID: 3088629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical detection of blood-brain barrier alteration by means of EEG. I. EEG effects induced by two anticholinesterase agents--the lipid-soluble physostigmine and the lipid-insoluble neostigmine--on two different types of focal cerebral lesion in man.
    Flodmark S
    Acta Neurol Scand Suppl; 1965; 13 Pt 1():163-77. PubMed ID: 4953786
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of scopolamine (0.6 mg), physostigmine (1.0 mg), and their complex on the blood pressure, the body temperature and the heart rate in man.
    Hrbek J; Komenda S; Macáková J; Siroká A; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1985; 112():279-94. PubMed ID: 2938438
    [No Abstract]   [Full Text] [Related]  

  • 15. Atropine, scopolamine, and ditran: comparative pharmacology and antagonists in man.
    Ketchum JS; Sidell FR; Crowell EB; Aghajanian GK; Hayes AH
    Psychopharmacologia; 1973 Jan; 28(2):121-45. PubMed ID: 4694622
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of hemicholinium (HC-3) and some anticholinesterases on the vascular responses to sympathetic nerve stimulation.
    Kayaalp SO
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):152-64. PubMed ID: 4383499
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular responses to intrahypothalamic injections of carbachol and certain cholinesterase inhibitors.
    Brezenoff HE
    Neuropharmacology; 1972 Sep; 11(5):637-44. PubMed ID: 4670595
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholinergic-adrenergic balance: Part 2. Relationship between drug sensitivity and personality.
    Fritze J; Sofic E; Müller T; Pfüller H; Lanczik M; Riederer P
    Psychiatry Res; 1990 Dec; 34(3):271-9. PubMed ID: 2075225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic transmission in the cat medulla oblongata in the initiation of vagal bradycardia.
    Varma DR
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):233-41. PubMed ID: 5941879
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of physostigmine, neostigmine and acetylcholine on serum magnesium concentration.
    TERKILDSEN TC
    Acta Pharmacol Toxicol (Copenh); 1952; 8(4):385-90. PubMed ID: 13016297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.